Home
Scientific News
Structural Heart Disease
Coronary Disease
Peripheral Vascular Disease
Pharmacology
Educational Newsletters for Fellows
Educational Webinars
Other Content
Congresses
SOLACI-SOCIME 2025 Congress
International Congresses
SOLACI Congresses
Upcoming Events
SOLACI Areas
Sessions
Venezuela Sessions 2025
Costa Rica Sessions 2025
Previous Sessions
About SOLACI Sessions
Authorities
SOLACI Sessions News
ProEducar
Educational Newsletters
Courses for Fellows
The Fellow’s Corner
ProEducar Videos and Webinars
ProEducar News
SOLACI Research
2025 SOLACI Research Grant
LATAM-SOLACI Peripheral Registry
LATAM-BIF SOLACI Registry
Participate in our LATAM-SOLACI Peripheral Registries
SOLACI/SIAC Clinical Guidelines TAVR vs SAVR
SOLACI-SIAC LM Revascularization Guidelines
Authorities
Videos and Webinars
Research News
SOLACI Peripheral
LATAM-SOLACI Peripheral Registry
Videos and Webinars
Authorities
SOLACI Peripheral News
MIL Group
Activities and Initiatives
Videos and Webinars
History, Mission, and Vision
Authorities
Mil Group News
CHIP LATAM SOLACI
Authorities
CHIP LATAM SOLACI News
SOL SOLACI
Authorities
SOL SOLACI News
Congenital Heart Disease
Authorities
Congenital Heart Disease News
SOLACI Technologists and Nurses
Board of Directors
Videos and Webinars
SOLACI Technologists and Nurses News
About SOLACI
About us
Board of Directors
List of members
Become A SOLACI Member
Update your Info (members)
Related Organizations
Institutional News
Contact
Search
Search
Search
SOLACI Congress
SOLACI & SBHCI 2026
Welcome to SOLACI & SBHCI 2026
Highlights
General Information
Authorities
SOLACI-SOCIME 2025 Certificates
Facebook
Instagram
Linkedin
Twitter
Youtube
Home
Scientific News
Structural Heart Disease
Coronary Disease
Peripheral Vascular Disease
Pharmacology
Educational Newsletters for Fellows
Educational Webinars
Other Content
Congresses
SOLACI-SOCIME 2025 Congress
International Congresses
SOLACI Congresses
Upcoming Events
SOLACI Areas
Sessions
Venezuela Sessions 2025
Costa Rica Sessions 2025
Previous Sessions
About SOLACI Sessions
Authorities
SOLACI Sessions News
ProEducar
Educational Newsletters
Courses for Fellows
The Fellow’s Corner
ProEducar Videos and Webinars
ProEducar News
SOLACI Research
2025 SOLACI Research Grant
LATAM-SOLACI Peripheral Registry
LATAM-BIF SOLACI Registry
Participate in our LATAM-SOLACI Peripheral Registries
SOLACI/SIAC Clinical Guidelines TAVR vs SAVR
SOLACI-SIAC LM Revascularization Guidelines
Authorities
Videos and Webinars
Research News
SOLACI Peripheral
LATAM-SOLACI Peripheral Registry
Videos and Webinars
Authorities
SOLACI Peripheral News
MIL Group
Activities and Initiatives
Videos and Webinars
History, Mission, and Vision
Authorities
Mil Group News
CHIP LATAM SOLACI
Authorities
CHIP LATAM SOLACI News
SOL SOLACI
Authorities
SOL SOLACI News
Congenital Heart Disease
Authorities
Congenital Heart Disease News
SOLACI Technologists and Nurses
Board of Directors
Videos and Webinars
SOLACI Technologists and Nurses News
About SOLACI
About us
Board of Directors
List of members
Become A SOLACI Member
Update your Info (members)
Related Organizations
Institutional News
Contact
Home
Scientific News
Structural Heart Disease
Coronary Disease
Peripheral Vascular Disease
Pharmacology
Educational Newsletters for Fellows
Educational Webinars
Other Content
Congresses
SOLACI-SOCIME 2025 Congress
International Congresses
SOLACI Congresses
Upcoming Events
SOLACI Areas
Sessions
Venezuela Sessions 2025
Costa Rica Sessions 2025
Previous Sessions
About SOLACI Sessions
Authorities
SOLACI Sessions News
ProEducar
Educational Newsletters
Courses for Fellows
The Fellow’s Corner
ProEducar Videos and Webinars
ProEducar News
SOLACI Research
2025 SOLACI Research Grant
LATAM-SOLACI Peripheral Registry
LATAM-BIF SOLACI Registry
Participate in our LATAM-SOLACI Peripheral Registries
SOLACI/SIAC Clinical Guidelines TAVR vs SAVR
SOLACI-SIAC LM Revascularization Guidelines
Authorities
Videos and Webinars
Research News
SOLACI Peripheral
LATAM-SOLACI Peripheral Registry
Videos and Webinars
Authorities
SOLACI Peripheral News
MIL Group
Activities and Initiatives
Videos and Webinars
History, Mission, and Vision
Authorities
Mil Group News
CHIP LATAM SOLACI
Authorities
CHIP LATAM SOLACI News
SOL SOLACI
Authorities
SOL SOLACI News
Congenital Heart Disease
Authorities
Congenital Heart Disease News
SOLACI Technologists and Nurses
Board of Directors
Videos and Webinars
SOLACI Technologists and Nurses News
About SOLACI
About us
Board of Directors
List of members
Become A SOLACI Member
Update your Info (members)
Related Organizations
Institutional News
Contact
Home
CONGRESS
CONGRESS
SOLACI Congresses
SOLACI-SOCIME 2022
News
The Best of Main Arena
Live Cases
The Best Moments of the Congress
Day 3
Day 2
View Category
Day 2
RESPECT: Randomized clinical trial evaluated the patent foramen oval closure vs clinical treatment in patients with cryptogenic stroke
Fundamentals: Etiology of cryptogenic stroke stills a major challenge for medicine. Paradoxical embolism remains one of the...
solaci
-
24 June, 2015
Learn More
Day 2
ADAPT-DES: Results at 1 year of the clinical impact of hypo-responders to aspirin and clopidogrel.
Background: The ADAPT-DES registry showed a strong correlation between hypo-responders to clopidogrel and the likelihood of stent...
solaci
-
24 June, 2015
Learn More
Day 2
POST trial: Post-conditioning effect in myocardial reperfusion with primary angioplasty.
Ischemic postconditioning obtained through reversible ischemia and reproduced during reperfusion after a prolonged ischemic injury has shown...
solaci
-
24 June, 2015
Learn More
Day 3
STEMI RADIAL A prospective, randomized trial which compares radial versus femoral access in patients with ST- segment elevation acute myocardial infarction.
Fundamentals: Previous studies have shown the benefits of a transradial approach in the context of coronary syndromes...
solaci
-
24 June, 2015
Learn More
Day 3
ISAR-DESIRE 3: A paclitaxel eluting balloon versus Taxus in the treatment of eluting stent restenosis.
Fundamentals. Background: Although we've had more than a decade of experience with implanting drug-eluting stents, (DES), the...
solaci
-
24 June, 2015
Learn More
Day 1
MASTER Trial: Prospective, multicentre, randomized trial evaluating the MGuard stent in the treatment of patients with acute myocardial infarction with ST segment elevation (STEMI).
Foreword: The EPS MGUARD stent (embolic protection stent) has a fine metal structure covered by a thin...
solaci
-
24 June, 2015
Learn More
Day 1
PARTNER cohort B: Clinical events at 3 years follow-up in patients with
Background: Percutaneous aortic valve implantation (TAVI) is the treatment of choice for patients with severe aortic stenosis...
solaci
-
24 June, 2015
Learn More
Day 1
ETAP: Endovascular treatment of atherosclerotic popliteal artery lesions: a prospective, multi-center, randomized study.
Introduction: The popliteal artery is a vessel considered unfavorable for the implantation of a stent due to...
solaci
-
24 June, 2015
Learn More